Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2
Deals & business · first seen 9h ago, updated 9h ago

Lilly extends China innovation push in $3.35B Innocare deal

1 outlet Eli Lilly

A preview of the next edition of BioWorld, Sept. 24, 2026

Summary from BioWorld Articles.

Coverage 2 articles · 1 outlet

  1. BioWorld Articles
    Lilly extends China innovation push in $3.35B Innocare deal
  2. BioWorld Articles
    Lilly extends China innovation push in $3.35B Innocare deal